| Announce Date | 01/20/2026 |
| EPS Normalized Actual | $3.1 (Beat by $0.17) |
| EPS GAAP Actual | $3.1 (Beat by $0.17) |
| Revenue Actual | $15.397B |
| Revenue Surprise | Beat by $15397M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 21.24 | 5.46 | 20.46936 | 21.76918 | 1 |
| Dec 2029 | 20.21 | 5.74 | 19.18546 | 20.76927 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 3.19 | 3.19 | 15.397B | 4.56% | 15397M |
| FQ3 2025 (Sep 2025) | 2.9 | 2.9 | 15.225B | 2.51% | 15225M |
| FQ2 2025 (Jun 2025) | 2.97 | 2.97 | 15.236B | 1.64% | 15236M |
| FQ1 2025 (Mar 2025) | 1.16 | 1.16 | 13.212B | 5.09% | 13212M |
| FQ4 2024 (Dec 2024) | 2.94 | 2.94 | 14.695B | 7.27% | 14695M |
| FQ3 2024 (Sep 2024) | 2.9 | 2.9 | 14.843B | 2.42% | 14843M |
| FQ2 2024 (Jun 2024) | 4.02 | 4.02 | 14.986B | 5.39% | 14986M |
| FQ1 2024 (Mar 2024) | -0.38 | -0.38 | 12.539B | 8.85% | 12539M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 5.464 | -- | 5.16554 | 5.65365 | 3 |
| FQ3 2029 (Sep 2029) | 5.4181 | -- | 5.12215 | 5.60616 | 6 |
| FQ2 2029 (Jun 2029) | 7.0533 | -- | 6.66803 | 7.29811 | 3 |
| FQ1 2029 (Mar 2029) | 2.3006 | -- | 2.17493 | 2.38045 | 3 |
| FQ4 2028 (Dec 2028) | 4.6918 | -- | 4.43552 | 4.85465 | 4 |
| FQ3 2028 (Sep 2028) | 4.6524 | -- | 4.39827 | 4.81388 | 6 |
| FQ2 2028 (Jun 2028) | 6.1682 | -- | 5.83127 | 6.38229 | 4 |
| FQ1 2028 (Mar 2028) | 1.7861 | -- | 1.68854 | 1.84809 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 19.57B | -- | 18.75B | 20.09B | 3 |
| FQ3 2029 (Sep 2029) | 19.46B | -- | 18.64B | 19.98B | 3 |
| FQ2 2029 (Jun 2029) | 19.8B | -- | 18.97B | 20.33B | 3 |
| FQ1 2029 (Mar 2029) | 16.76B | -- | 16.06B | 17.21B | 4 |
| FQ4 2028 (Dec 2028) | 18.65B | -- | 17.87B | 19.15B | 3 |
| FQ3 2028 (Sep 2028) | 18.54B | -- | 17.76B | 19.04B | 4 |
| FQ2 2028 (Jun 2028) | 18.87B | -- | 18.08B | 19.37B | 5 |
| FQ1 2028 (Mar 2028) | 15.97B | -- | 15.3B | 16.4B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 3.19 | 3.19 | 100% | |
| FQ3 2025 (Sep 2025) | 2.9 | 2.9 | 100% | |
| FQ2 2025 (Jun 2025) | 2.97 | 2.97 | 100% | |
| FQ1 2025 (Mar 2025) | 1.16 | 1.16 | 100% | |
| FQ4 2024 (Dec 2024) | 2.94 | 2.94 | 100% | |
| FQ3 2024 (Sep 2024) | 2.9 | 2.9 | 100% | |
| FQ2 2024 (Jun 2024) | 4.02 | 4.02 | 100% | |
| FQ1 2024 (Mar 2024) | -0.38 | -0.38 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $15.4B | $15397M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $15.23B | $15225M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $15.24B | $15236M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $13.21B | $13212M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $14.7B | $14695M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $14.84B | $14843M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $14.99B | $14986M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $12.54B | $12539M | 100% |